Diabetes Care 28:2130-2135, 2005
© 2005 by the American Diabetes Association, Inc.
Epidemiology/Health Services/Psychosocial Research Original Article |
The Burden of Mortality Attributable to Diabetes
Realistic estimates for the year 2000
Gojka Roglic, MD1,
Nigel Unwin, DM, MFPH1,
Peter H. Bennett, MB, FRCP2,
Colin Mathers, BSC, PHD3,
Jaakko Tuomilehto, MD, PHD4,5,6,
Satyajit Nag, MRCP7,
Vincent Connolly, MD, FRCP7 and
Hilary King, MD, DSC1
1 Department of Chronic Diseases and Health Promotion, World Health Organization, Geneva, Switzerland
2 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona
3 Measurement and Health Information, World Health Organization, Geneva, Switzerland
4 Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, Finland
5 Department of Public Health, University of Helsinki, Helsinki, Finland
6 South Ostrobotnia Central Hospital, Seinäjoki, Finland
7 Diabetes Care Centre, The James Cook University Hospital, Middlesborough, U.K.
Address correspondence and reprint requests to Dr. Gojka Roglic, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland. E-mail: roglicg{at}who.int
OBJECTIVETo estimate the global number of excess deaths due to diabetes in the year 2000.
RESEARCH DESIGN AND METHODSWe used a computerized generic formal disease model (DisMod II), used by the World Health Organization to assess disease burden through modeling the relationships between incidence, prevalence, and disease-specific mortality. Baseline input data included population structure, age- and sex-specific estimates of diabetes prevalence, and available published estimates of relative risk of death for people with diabetes compared with people without diabetes. The results were validated with population-based observations and independent estimates of relative risk of death.
RESULTSThe excess global mortality attributable to diabetes in the year 2000 was estimated to be 2.9 million deaths, equivalent to 5.2% of all deaths. Excess mortality attributable to diabetes accounted for 23% of deaths in poorest countries and over 8% in the U.S., Canada, and the Middle East. In people 3564 years old, 627% of deaths were attributable to diabetes.
CONCLUSIONSThese are the first global estimates of mortality attributable to diabetes. Globally, diabetes is likely to be the fifth leading cause of death.
Abbreviations: DECODA, Diabetes Epidemiology, Collaborative Analysis of Diagnostic Criteria in Asia DECODE, Diabetes Epidemiology, Collaborative Analysis of Diagnostic Criteria in Europe WHO, World Health Organization

CiteULike Del.icio.us Digg Reddit Technorati What's this?
Related Article:
-
Progress in the Estimation of Mortality due to Diabetes
- Edward J. Boyko
Diabetes Care 2005 28: 2320-2321.
[Extract]
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
J. Ormel, M. Petukhova, S. Chatterji, S. Aguilar-Gaxiola, J. Alonso, M. C. Angermeyer, E. J. Bromet, H. Burger, K. Demyttenaere, G. de Girolamo, et al.
Disability and treatment of specific mental and physical disorders across the world
The British Journal of Psychiatry,
May 1, 2008;
192(5):
368 - 375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rewers
Why Do People With Diabetes Die Too Soon?: More questions than answers
Diabetes Care,
April 1, 2008;
31(4):
830 - 832.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Yang, W. Y. So, P. C. Y. Tong, R. C. W. Ma, A. P. S. Kong, C. W. K. Lam, C. S. Ho, C. S. Cockram, G. T. C. Ko, C.-C. Chow, et al.
Development and Validation of an All-Cause Mortality Risk Score in Type 2 Diabetes: The Hong Kong Diabetes Registry
Arch Intern Med,
March 10, 2008;
168(5):
451 - 457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-W. Kwon, Y.-m. Song, H. s. Park, J. Sung, H. Kim, and S.-i. Cho
Effects of Age, Time Period, and Birth Cohort on the Prevalence of Diabetes and Obesity in Korean Men
Diabetes Care,
February 1, 2008;
31(2):
255 - 260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W. Franks, R. L. Hanson, W. C. Knowler, C. Moffett, G. Enos, A. M. Infante, J. Krakoff, and H. C. Looker
Childhood Predictors of Young-Onset Type 2 Diabetes
Diabetes,
December 1, 2007;
56(12):
2964 - 2972.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wolfram
Effects of Green Tea and EGCG on Cardiovascular and Metabolic Health
J. Am. Coll. Nutr.,
August 1, 2007;
26(4):
373S - 388S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. H. Franco, E. W. Steyerberg, F. B. Hu, J. Mackenbach, and W. Nusselder
Associations of Diabetes Mellitus With Total Life Expectancy and Life Expectancy With and Without Cardiovascular Disease
Arch Intern Med,
June 11, 2007;
167(11):
1145 - 1151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Avogaro, C. Giorda, M. Maggini, E. Mannucci, R. Raschetti, F. Lombardo, S. Spila-Alegiani, S. Turco, M. Velussi, E. Ferrannini, et al.
Incidence of Coronary Heart Disease in Type 2 Diabetic Men and Women: Impact of microvascular complications, treatment, and geographic location
Diabetes Care,
May 1, 2007;
30(5):
1241 - 1247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. M Montori, W. L Isley, and G. H Guyatt
Waking up from the DREAM of preventing diabetes with drugs
BMJ,
April 28, 2007;
334(7599):
882 - 884.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P.S. Kong, X. Yang, G. T.C. Ko, W.-Y. So, W.-B. Chan, R. C.W. Ma, V. W.S. Ng, C.-C. Chow, C. S. Cockram, P. C.Y. Tong, et al.
Effects of Treatment Targets on Subsequent Cardiovascular Events in Chinese Patients With Type 2 Diabetes
Diabetes Care,
April 1, 2007;
30(4):
953 - 959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J M A Hannan, L. Marenah, L. Ali, B. Rokeya, P. R Flatt, and Y. H Abdel-Wahab
Insulin secretory actions of extracts of Asparagus racemosus root in perfused pancreas, isolated islets and clonal pancreatic {beta}-cells
J. Endocrinol.,
January 1, 2007;
192(1):
159 - 168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
The DREAM Trial Investigators
Effect of Ramipril on the Incidence of Diabetes
N. Engl. J. Med.,
October 12, 2006;
355(15):
1551 - 1562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. T. Cefalu
Glycemic Control and Cardiovascular Disease -- Should We Reassess Clinical Goals?
N. Engl. J. Med.,
December 22, 2005;
353(25):
2707 - 2709.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Boyko
Progress in the Estimation of Mortality due to Diabetes
Diabetes Care,
September 1, 2005;
28(9):
2320 - 2321.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Diabetes Association.
|
|
| |
|